NCT07921017 Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
| NCT ID | NCT07921017 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Rotator Cuff Tendonitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2026-10-29 |
| Primary Completion | 2026-12-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2026-10-29 with a primary completion date of 2026-12-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effects of cervicothoracic junction mobilization on pain, shoulder range of motion (ROM), and disability in patients with supraspinatus tendinitis. A randomized controlled trial will include 62 participants divided into experimental and control groups. The experimental group will receive cervicothoracic mobilization alongside conventional physiotherapy, while the control group will receive conventional physiotherapy only. Outcomes will be assessed using NPRS, a goniometer, and SPADI. Data will be analyzed using IBM SPSS, with results reported after data collection and analysis.
Eligibility Criteria
Inclusion Criteria: * Male and female patients both are included age ranging from 25 to 45 years. * Diagnosis confirmed through Jobe's Test (Empty can) and characteristic signs and symptoms of supraspinatus tendinitis. Exclusion Criteria: * History of any previous surgical intervention involving the shoulder. * Shoulder joint instability due to causes other than supraspinatus pathology. * Presence of acromioclavicular joint arthritis. * Participants were excluded if they had osteoporosis, spinal fractures, or tumors.
Contact & Investigator
Ali Raza, Mphill
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07921017 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 45 Years, studying Rotator Cuff Tendonitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07921017 currently recruiting?
Yes, NCT07921017 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07921017 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07921017 clinical trial?
NCT07921017 is sponsored by Riphah International University. The principal investigator is Ali Raza, Mphill at Riphah International University. The trial plans to enroll 62 participants.